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Mapping the genetic diversity of 
HLA haplotypes in the Japanese 
populations
Woei-Yuh Saw1,2, Xuanyao Liu1,3, Chiea-Chuen Khor4, Fumihiko Takeuchi5, 
Tomohiro Katsuya6, Ryosuke Kimura7, Toru Nabika8, Takayoshi Ohkubo9, Yasuharu Tabara10, 
Ken Yamamoto11, Mitsuhiro Yokota12, Japanese Genome Variation Consortium‡,  
Yik-Ying Teo1,2,3,4,5,13,* & Norihiro Kato5,*
Japan has often been viewed as an Asian country that possesses a genetically homogenous community. 
The basis for partitioning the country into prefectures has largely been geographical, although cultural 
and linguistic differences still exist between some of the districts/prefectures, especially between 
Okinawa and the mainland prefectures. The Major Histocompatibility Complex (MHC) region has 
consistently emerged as the most polymorphic region in the human genome, harbouring numerous 
biologically important variants; nevertheless the presence of population-specific long haplotypes 
hinders the imputation of SNPs and classical HLA alleles. Here, we examined the extent of genetic 
variation at the MHC between eight Japanese populations sampled from Okinawa, and six other 
prefectures located in or close to the mainland of Japan, specifically focusing at the haplotypes 
observed within each population, and what the impact of any variation has on imputation. Our results 
indicated that Okinawa was genetically farther to the mainland Japanese than were Gujarati Indians 
from Tamil Indians, while the mainland Japanese from six prefectures were more homogeneous 
than between northern and southern Han Chinese. The distribution of haplotypes across Japan was 
similar, although imputation was most accurate for Okinawa and several mainland prefectures when 
population-specific panels were used as reference.
The advent of high-throughput genotyping technology has considerably advanced our understanding of human 
genetic variation globally. Landmark studies such as the Human Genome Diversity Project1, the International 
HapMap Project2–4, the Singapore Genome Variation Project5 and more recently the African Genome Variation 
Project6,7 have unveiled unprecedented insights into the genetic diversity of global populations8–13, as well as 
facilitated our understanding of human evolution and adaptation14–17. The Major Histocompatibility Complex 
(MHC) region on the short arm of chromosome 6 has consistently emerged in all of these studies as the most 
polymorphic region in the human genome. Spanning about 4 Mb, the MHC contains over 160 genes including 
the human leukocyte antigen (HLA) Class I and Class II genes, thus allowing this genomic region to play a central 
role in regulating the human immune system as well as in determining the compatibility of organ transplants, 
susceptibility to infectious and autoimmune disorders and adverse reactions to pharmacologic agents18–22.
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Studies have reported considerable genetic differences at the MHC between global populations18,23, although 
this was similarly observed between seemingly homogeneous populations, such as the northern and southern Han 
Chinese24, and the Hondo and Ryukyu Japanese25. In the latter study by Yamaguchi-Kabata and colleagues, SNPs 
located in the HLA region were found to display the greatest allele frequency differences between the mainland 
Japanese (Hondo) and Japanese residing in the Ryukyu islands, when compared to SNPs found across the rest of 
the genome.
Although the classical serotyping, and the subsequent conversion to the HLA allele nomenclature, provides 
the most biologically relevant information, the availability of this information for global populations lags consid-
erably as compared to the availability of SNP data18. This has led to clever strategies to statistically infer what the 
underlying HLA alleles are on the basis of SNP-level information, in a process known as HLA imputation which 
compares the target SNP data against a reference panel possessing both SNP and HLA allele data18,26. However, the 
accuracy of this imputation process has been shown to depend critically on whether the reference panel possesses 
populations that are genetically representative of the target population27,28, as underlying haplotype differences 
between the target and reference populations can distort this process of statistical copying. In the absence of a 
comprehensive HLA and SNP reference database, one useful indicator of how successful the imputation will be at 
recovering the HLA alleles is thus to survey the extent of haplotype diversity at Class I and Class II gene regions 
between the target SNP data and the reference database.
In this study, we investigate the extent of haplotype diversity in HLA Class I and Class II genes across eight 
Japanese populations, comprising Ryukyu samples from the Okinawa prefecture and seven groups of samples from 
six prefectures, located in or close to the mainland of Japan. To benchmark the extent of genetic diversity seen in 
these eight populations, we performed the same analyses between: (i) East Asian samples with ancestries originating 
from North and South China; and (ii) South Asian samples with ancestries originating from the Gujarat state in 
North India and from the Tamil-Nadu state in South India (Fig. 1). In order to measure the impact of the genetic 
differences present between the eight Japanese populations, we also evaluated the accuracy of SNP imputation in 
these populations with existing data from the HapMap panel, as a surrogate inference measure of how well the 
imputation can recover the HLA alleles for these eight Japanese populations.
Materials and Methods
Sample collection and genotyping. This study considered 1,400 Japanese individuals which is a subset of 
the 3,933 subjects in Asian Diversity Project (ADP), comprising 200 subjects each from seven regions (prefectures 
or cities): Amagasaki (in Hyogo Prefecture), Ehime, Fukuoka, Kita-nagoya (in Aichi Prefecture), Okinawa, Shimane 
and Tokyo. We additionally considered 85 unrelated Japanese samples from Tokyo in Phase 3 of the International 
HapMap Project (HapMap)29, which are specifically abbreviated as JPT to avoid confusing with the Tokyo samples 
from the ADP. For benchmarking, we considered the South Asian samples from the: (i) HapMap, comprising 85 
unrelated Gujarati Indians in Houston (GIH); (ii) Singapore Genome Variation Project (SGVP), comprising 83 
Tamil Indians in Singapore (INS); as well as the East Asian samples from the: (i) HapMap, comprising 84 unrelated 
Han Chinese in Beijing (CHB), which is reflected of ancestry from North China; and (ii) SGVP, comprising 96 
Chinese in Singapore (CHS) which is reflected of Han Chinese ancestry from South China.
Four of the seven Japanese populations from the ADP (i.e., Amagasaki, Ehime, Fukuoka and Kita-nagoya) were 
genotyped on the Illumina Omni 2.5 M array, while samples from Shimane and Tokyo were genotyped on the 
Illumina HumanHap550, and samples from Okinawa were genotyped on the Illumina OmniExpress. The HapMap 
and SGVP samples were genotyped on both the Affymetrix SNP6.0 and the Illumina Human1M. Only SNPs with 
call rates greater than 95% and with no departure from Hardy-Weinberg equilibrium (defined as PHWE > 0.05) 
were retained in our analysis, while all samples were used as these data have been already subject to prior quality 
control in previous publications5,29–35. Summary of the details of the population data we have used can be found 
in Supplementary Table 1.
Figure 1. Coverage of Japanese and benchmarking populations. Illustration of the coverage of the 
populations tested in this study, which includes eight populations from seven prefectures in Japan, two Han 
Chinese populations and two South Asian populations. Each circle highlights the geographical location of 
a population, from which the ancestry of that population is expected to originate from. The figure map was 
created using the R package “maps”50 and “mapdata”51 in R52 software.
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Basic information of seven Japanese population data. This study considered a total of 1,400 Japanese 
individuals, comprising 200 subjects each from seven regions (prefectures or cities) in Japan: Amagasaki (in Hyogo 
Prefecture), Ehime, Fukuoka, Kita-Nagoya (in Aichi Prefecture), Okinawa, Shimane and Tokyo, apart from 85 
unrelated Japanese subjects from Tokyo in Phase 3 of the International HapMap Project, abbreviated as HapMap 
JPT. Blood samples were collected in the individual regions for anthropology and/or genetic epidemiology study. 
All participants from the different studies provided written informed consent, and the local ethics committees 
approved the protocols30–35. All genotyping were performed in accordance with relevant guidelines and regula-
tions of the local institutes30–35. Apart from the Okinawa individuals, detailed information on the origin of four 
grandparents was not obtained for sampling criteria.
Amagasaki. The Amagasaki Study is an ongoing population-based cohort study of 5,743 individuals (3,435 males 
and 2,310 females), aged > 18 years and recruited for a baseline examination between September 2002 to August 
200329. The protocol of this study was approved by the Ethics Committee of the International Medical Center of 
Japan30. All study subjects provided written informed consent for the participation.
Ehime. Participants in the Anti-aging study cohort (AASC) are middle-aged to elderly persons who were con-
secutive participants in the medical check-up program at Ehime University Hospital Anti-aging Center31. This 
medical check-up program is provided to general residents of Ehime Prefecture, and is specifically designed to 
evaluate aging-related disorders, including arteriosclerosis, cardiovascular diseases, physical function, and cognitive 
function. All study subjects provided informed consent and this study was approved by the ethics committee of 
Ehime University Graduate School of Medicine31.
Fukuoka. The Kyushu University Fukuoka Cohort Study is a community-based prospective epidemiologic cohort 
of 12,959 subjects, who participated in the baseline survey during the period from February 2004 to August 200732. 
From this cohort, 12,569 subjects completed the questionnaire and also provided DNA for genotyping of SNPs to 
investigate lifestyle factors and genetic susceptibility of the so-called lifestyle-related diseases such as cardiovascu-
lar diseases, cancer, and diabetes mellitus. All participants provided written informed consent and this study was 
approved by the Ethics Committee of the Kyushu University Faculty of Medical Sciences32.
Kita-Nagoya. The Kita-Nagoya Genomic Epidemiology (KING) study (ClinicalTrials.gov identifier: 
NCT00262691) is an ongoing community-based prospective observational study of the genetic basis of cardio-
vascular disease and its risk factor33. The study recruited 3,975 Japanese subjects aged 50–80 years, who underwent 
community-based annual health checkups between May 2005 and December 2007. This study was approved by 
the Ethics Review Board of Nagoya University School of Medicine and all participants provided written informed 
consent33.
Okinawa. In the study of the Ryukyu population, only individuals, whose four grandparents were originated 
from the Ryukyu Islands, were included34. All participants provided written informed consent and this study was 
approved by the ethical committees at University of the Ryukyus, Showa University, and Kitasato University34.
Shimane and Tokyo. The Cardio-metabolic Genome Epidemiology (CAGE) Network is an ongoing collaborative 
effort to investigate genetic and environmental factors, and their interactions affecting cardiometabolic traits/dis-
orders among Asian populations, including the Japanese, Vietnamese and Sri Lankan35. CAGE participants were 
recruited in a population-based or hospital-based setting, depending on the design of member studies. From this 
network, subjects were enrolled at separate sites in Japan including the Tokyo and Shimane districts. Subjects in 
the Shimane district are people who visited the Shimane Institute of Health Science for a health screening exam-
ination between July 2003 and March 2007. Subjects in the Tokyo district were selected from participants in the 
Hospital-based Cohort Study at the National Center for Global Health and Medicine (NCGM), Tokyo, to investigate 
lifestyle factors and genetic susceptibility for lifestyle-related diseases. All participants from these studies provided 
written informed consents, and the local ethics committees approved the protocols.
Haplotype phasing. The genotype data for all the Japanese populations were phased with BEAGLE version 
3.3.236 to obtain the haplotype data necessary for our analysis of haplotype diversity. Although phased haplotypes 
for the HapMap and SGVP samples were available from the respective websites, these have been phased using 
PHASE and fastPHASE respectively. To avoid confounding the analyses due to the phasing algorithm used, the 
genotype data for the HapMap and SGVP samples were similarly phased with BEAGLE using the same settings. 
The analysis of haplotype diversity subsequently focused on a set of 1,607 SNPs between 25 Mb and 35 Mb on 
chromosome 6 (NCBI Build 37) that were present across all 12 populations studied.
Population structure analyses with SNP-level FST. To investigate the extent of allele frequency differ-
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where p1 and p2 denote the frequency of a particular allele in the two populations respectively. This was calculated 
between every pair of populations in the collection of eight Japanese and four benchmarking populations.
Population structure analyses with haplotype-level FST. Our analyses considered six HLA genes: 
HLA-A, HLA-B, HLA-C, HLA-DR, HLA-DQ and HLA-DP for the purpose of measuring the extent of diversity 
in the observed haplotypes in the MHC region. For each of the six HLA genes, a buffer region of 100 kb up- and 
downstream is appended and the distinct haplotypes that are formed by the SNPs located within this extended 
gene region is considered. The multi-allelic version of FST in ARLEQUIN version 3.137 is calculated using the 
observed population frequency of each haplotype to yield a haplotype-based measure of FST for each gene locus 
between every pair of populations. Since the samples were characterized with SNP arrays alone in the present 
study, the HLA haplotype data were not converted to the HLA allele nomenclature but arbitrarily numbered in 
the individual HLA genes.
Population structure analyses with principal component analysis (PCA). A series of PCAs were 
performed with different input. The first set of three PCAs were performed with smartPCA in the EIGENSOFT 
package38 using the genotype data at 240,332 SNPs present across the 12 populations, to investigate the popu-
lation structure of the: (i) 12 populations; (ii) eight Japanese and two Han Chinese populations; and (iii) seven 
Japanese populations from the six mainland regions. The second set of three PCAs were performed with an 
eigen-decomposition of a K × K distance matrix, where the (i, j) element in the matrix is given by the average 
SNP-level FST between population i and population j, averaged across 1,607 common SNPs present in the interval 
between 25 Mb and 35 Mb on chromosome 6. The second set of three PCAs considered the same population set as 
the first set of three PCAs, between 12 (K = 12), eight (K = 8) and seven (K = 7) populations respectively. The third 
set of three PCAs was similar in construct to the second set, except that the analysis considered the haplotype-based 
FST at each of the six HLA genes.
Evaluating imputation performance in the MHC region. We performed a series of SNP imputation in 
the different Japanese populations to evaluate the performance of the different population-specific and combined 
reference panels at the MHC. The target data to perform the imputation comprised 19 new subjects from each of 
the seven Japanese populations which similarly possessed the same 1,607 SNPs, although we masked 400 random 
SNPs and used the remaining 1,207 SNPs as input for imputation. Each population was imputed nine times, against 
the eight single-population reference panels and the combined East Asian reference panel which was derived from 
a combination of the CHB, CHS, JPT and Southeast Asian Malay samples from the SGVP or HapMap. Each of the 
seven population-specific panels consisted of 200 individuals, while the combined East Asian panel consisted of a 
modestly larger size with 350 individuals. The squared Pearson correlation coefficient (r2) between the observed 
genotype and the imputed allele dosage was calculated for the 400 masked SNPs across the 19 samples, and for the 
purpose of benchmarking imputation performance, we defined the discordance rate as 1 – r2. For benchmarking, 
the Han Chinese and Indian samples were similarly included in the imputation analyses, as both reference panels 
for the Japanese and as target data to be imputed, although the accuracy of the imputation for these samples with 
population-specific panels was not meaningful due to overfitting. All imputation was performed with IMPUTE 
version 2.3.039.
Results
Measuring genetic distance at the MHC with SNP-level FST. Between 25 Mb and 35 Mb on chromo-
some 6, a total of 1,607 SNPs were present in our data comprising the eight Japanese populations and the four 
HapMap and SGVP populations. The genetic distance between every pair of these 12 populations was measured 
by the average SNP-level FST values across these 1,607 SNPs. Between the eight Japanese populations, Okinawa 
stood out as the most distinct population, showing a minimum FST of 0.6% with Ehime and a maximum FST of 
1.0% with Fukuoka, Shimane and Tokyo (Supplementary Table 1). The remaining seven Japanese populations 
were comparatively more homogeneous, with genetic distances in the order of 0.1% to 0.3%; the latter figure was 
observed in the comparison of population pairs mostly involving Ehime. The genetic distances calculated from the 
same 1,607 SNPs between North and South Chinese (CHB, CHS), and between North and South Indians (GIH, 
INS) were used to benchmark the distances seen in the Japanese populations. The distance between CHB and CHS 
was 0.4%, while the distance between GIH and INS was 0.5%, suggesting that the mainland Japanese populations 
were more homogeneous than Han Chinese from North and South China at the MHC region, whereas Okinawa 
was more distinct from the rest of the mainland Japanese populations than the case for genetic differences between 
the Gujarati and Tamil Indians.
Principal component analyses of population structure. In a preliminary PCA of 1,833 samples with 
genomewide data across 240,332 common SNPs in the eight Japanese and four benchmarking populations, it was 
evident that the two South Asian populations (GIH, INS) were significantly distinct from the East Asian populations 
(CHB, CHS, JPT, seven Japanese populations), although it was also clear that there were three genetic sub-clusters 
that corresponded to the Okinawa samples, Han Chinese and mainland Japanese respectively (Fig. 2A). The 
Okinawa samples were clearly distinguished from the Han Chinese and mainland Japanese samples in a manner 
that did not suggest that the Okinawa samples were admixed between the mainland Japanese and the Han Chinese 
(Fig. 2A,B), as the Okinawa samples were found in the opposite spectrum to the Han Chinese in the respective 
principal components. This is in good agreement with a number of findings in the history of human populations 
in the Japanese Archipelago; i.e., a dual structure model on the Japanese Archipelago populations40. In the PCA 
of 1,285 mainland Japanese, however, there was no evidence of any observable sub-structures between the seven 
populations in the analysis of genomewide data (Fig. 2C).
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We also performed a series of population-level PCAs using the K × K distance matrices (K represents the 
number of populations) constructed from the 1,607 SNPs in the 10 Mb region on chromosome 6 (see Materials 
and Methods for details). This effectively represented the genetic distance using the FST metric to quantify the 
extent of allele frequency differences between pairs of populations. These analyses similarly distinguished the 
South Asians and Han Chinese from the Japanese samples (Fig. 3A,B), as well as the Okinawa samples from 
the mainland Japanese samples (Fig. 3B), but appeared to provide greater resolution to the genetic differences 
within the seven mainland Japanese populations where Ehime and Shimane appeared to be more distinct from 
the remaining five populations (Fig. 3C). These observations were remarkably concordant with what we saw for 
the genomewide data, especially when we summarized the observations in Fig. 2 by averaging the sample-level 
principal component coordinates in each population to yield a single population-level coordinates for that pop-
ulation (Supplementary Figure 1). To further investigate the observed distinction between Ehime and Shimane 
and the remaining mainland Japanese populations, we pooled the FST values calculated for the 1,607 SNPs across 
all possible pairs of the seven mainland Japanese populations to produce an overall FST distribution. By identifying 
the FST values in the top 1%, we observed that there was a significant over-representation from population-pairs 
involving Ehime (PBinomial = 0.0011) and Shimane (PBinomial = 1.38 × 10−15) . The distinction between Ehime and 
Shimane and the rest of the mainland Japanese samples was similarly observed in the haplotype-based PCAs at 
the six HLA genes (Supplementary Figure 2). Notably, the genetic differences within the seven mainland Japanese 
populations appeared to be more pronounced at Class II gene regions (HLA-DR, -DQ and –DP) than Class I gene 
regions (HLA-A, -B and -C) (Supplementary Figure 2).
Figure 2. Subject-level principal component analyses with genomewide SNP data. Biplots are shown for the 
first two axes of variations from three different principal component analyses (PCAs) of 240,332 SNPs that are 
present across the genome in the eight Japanese populations and the four benchmarking populations from East 
and South Asia. The three different PCAs were performed on (A) all 12 populations; (B) only the eight Japanese 
and two Han Chinese populations; and (C) only the seven populations from mainland Japan. Each circle 
represents an individual from a particular population and is assigned a colour unique to that population that is 
represented in the legend on the bottom right panel.
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Haplotype differences between populations. Haplotypes for the 1,607 SNPs were obtained by phasing 
the genotype data for the 12 populations with BEAGLE. This allowed us to examine the distribution of the major 
haplotypes at each of the six HLA genes in each of these populations (Table 1). The definition for major haplotypes 
is quite arbitrary. In our study, for HLA-A, HLA-B, HLA-C, HLA-DR, we defined a major haplotype as possessing 
a population frequency of at least 10% in any of the 12 populations. While, for HLA-DQ and HLA-DP, we defined 
a major haplotype as possessing a population frequency of at least 6% in any of the 12 populations. This is due to 
the large number of haplotypes found across a larger set of SNPs at HLA-DQ and HLA-DP.
Unsurprisingly, there were ancestry-specific haplotypes that were found only in South Asians or in East Asians, 
and the majority of the major haplotypes in Japan were shared across the different Japanese populations except that 
the haplotype frequencies varied between the populations to some extent (Fig. 4, Supplementary Figures 3–7). For 
example, in the case of HLA-B, although there were 373 distinct haplotypes from 74 SNPs at this locus, there were 
only eight major haplotypes in the 12 populations. Five of the eight major haplotypes were absent in South Asian 
populations (H1, H2, H3, H4, H7), while H8 was not found in any of the eight Japanese populations (Fig. 4A). One 
of the haplotypes (H3) appeared to be unique to the Japanese populations, and we observed that the frequency of 
H4 varied from 1.7% in Okinawa to 14.2% in both Fukuoka and Shimane (Fig. 4B). However, it should be noted 
that majority of the major haplotypes found in the HLA genes were present in all the Japanese populations and 
were in common with the other East and/or South Asian populations used for benchmarking (Fig. 5).
As our analysis of haplotype diversity considered mutually-distinct haplotypes that are found within a genomic 
region in each population, it is useful to measure to which extent these distinct haplotypes are assumed to differ. 
By calculating the percentage of SNP sites which differed between any two haplotypes at a locus, we observed that 
Figure 3. Population-level principal component analyses with SNPs at the MHC. Biplots are shown for 
the first two axes of variations from eigen-decompositions of distance matrices that were calculated from the 
average FST values between pairs of populations across 1,607 SNPs found in the interval between 25Mb and 
35Mb of chromosome 6 in the eight Japanese populations and the four benchmarking populations from East 
and South Asia. Three different analyses were performed, involving (A) all 12 populations; (B) only the eight 
Japanese and two Han Chinese populations; and (C) only the seven populations from mainland Japan. Each 
circle represents a particular population and is colored with the same unique colour for that population as 
represented in the legend on Fig. 2.
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the majority of the major haplotypes found at the HLA loci were substantially different to each other at the level 
of SNPs forming individual haplotypes except at HLA-A where there were four major haplotypes that differed 
by only a single SNP (Table 2). Imputation performance in the MHC region with different reference panels.
An immediate consequence of haplotype variations between different Japanese populations is the impact on 
imputation accuracy. We investigated this in two manners: firstly, whether the accuracy changed when different 
single-population panels were used to impute SNP data for each Japanese population; and secondly, whether the 
use of a combined East Asian panel, which consists of Chinese, Japanese and Malays from public databases such as 
the HapMap and the SGVP, will yield better performance. The different reference panels except for the combined 
panel were deliberately chosen to be of comparable sizes in order to avoid any confounding due to sample size, to 
allow for investigation of the impact of haplotype diversity. Also, to avoid over-fitting, 19 additional samples from 
each of the Japanese populations (except HapMap JPT) were used as the target data for imputation.
We observed that the use of either the HapMap JPT panel or the combined East Asian panel yielded marginally 
higher discordance rates, when compared to the use of most of the single-population panels (Fig. 6, Supplementary 
Table 2). The latter result was surprising as the combined East Asian panel was almost double the size of the 
single-population panels. When imputed against single-population panels, Ehime and Okinawa samples yielded the 
lowest discordance rates only when the respective population-specific reference panels were used (Supplementary 
Table 2), providing another line of evidence to support that these two populations were more distinct from the 
other Japanese populations.
Three other Japanese populations (Shimane, Amagasaki, Kita-nagoya) similarly produced the lowest discord-
ance rates when the respective population-specific reference panels were used, although this was not unique to 
the population-specific reference panels; there were at least one other single-population panel that yielded an 
equivalent level of discordance rates. For example, the lowest discordance rate of 2% was seen in Shimane when 
either the Shimane panel or the Amagasaki panel was used as reference. It was also evident that the use of reference 
HLA gene Start Position End Position Number of SNPs Number of Unique Haplotypes
HLA-A 29,810,247 30,013,868 39 110
HLA-B 31,221,649 31,424,989 74 373
HLA-C 31,136,526 31,339,913 67 377
HLA-DR (merging DRA1 and DRB1) 32,307,619 32,657,613 61 363
HLA-DQ (merging DQA1and DQB1) 32,505,183 32,734,466 70 518
HLA-DP (merging DPA1 and DPB1) 32,932,346 33,153,681 87 890
Table 1.  Details of the six HLA genes (loci) in Class I (HLA-A, HLA-B, HLA-C) and Class II (HLA-DR, 
HLA-DQ, HLA-DP) in this study, and the number of SNPs found within each locus, which were commonly 
assayed across all 12 study populations. The genomic physical positions of each gene region are based on 
NCBI Build 37.
Figure 4. Distribution of major haplotypes at HLA-B. Distribution of major haplotypes found across the 
eight Japanese populations and the four benchmarking populations from East and South Asia at HLA-B, 
where the frequencies are illustrated (A) in piecharts according to the expected geographical locations, which 
correspond to the ancestries of the respective populations; (B) in barcharts to indicate the percentages for each 
of the major haplotypes in the 12 populations. Eight major haplotypes were observed at HLA-B, out of 373 
unique haplotypes formed by 74 SNPs. The distribution of the major haplotypes in each of the piechart does not 
indicate the total sum of the frequency of the haplotypes, as label “others” was not included. The figure map was 
created using the R package “maps”50 and “mapdata”51 in R52 software.
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panels constructed from Han Chinese or Indians yielded comparatively poorer imputation performance for the 
Japanese samples.
Discussion
Our study has examined the genetic diversity between eight Japanese populations, comprising samples from 
Okinawa Prefecture and seven other populations samples from six prefectures, located in or close to the mainland 
of Japan. Our analyses focused on evaluating the genetic variation seen in the HLA Class I and Class II genes at 
the MHC, especially on how haplotypes differed between these populations as a surrogate to infer imputation 
performance for recovering the classical HLA alleles with SNP-level data. We used two pairs of populations from 
South Asia (GIH, INS) and East Asia (CHB, CHS) to benchmark the extent of genetic differences observed in 
the Japanese populations. There were multiple lines of evidence to support that Okinawa (Ryukyu) samples from 
Okinawa Prefecture were distinct from the mainland Japanese individuals, even more distinct than the case for 
genetic differences between North and South Indians. While mainland Japanese were comparatively more homog-
enous than Han Chinese, samples from Ehime Prefecture appeared to be marginally different from the remaining 
mainland Japanese individuals. The genetic differences observed between the eight Japanese populations can be 
Figure 5. Distribution of major haplotypes across the three main ancestry groups. The eight Japanese 
populations and the four benchmarking populations from East and South Asia were categorised into three 
main ancestry groups, corresponding to the Japanese, the South Asian Indians and the East Asian Chinese. The 
major haplotypes observed across the six HLA genes were represented in the Venn diagram to illustrate whether 
they were present in each ancestry group, defined as exhibiting a non-zero frequency in at least one of the 














H1 28.21 29.73 16.42 32.79 34.29 16.09
H2 2.56 2.70 17.91 32.79 21.43 11.49
H3 2.56 28.38 25.37 34.43 21.43 44.83
H4 28.21 32.43 28.36 32.79 24.29 25.29
H5 2.56 29.73 16.42 27.87 18.57 16.09
H6 28.21 2.70 17.91 27.87 8.57 11.49
H7 2.56 37.83 25.37 – 24.29 14.94
H8 35.90 18.92 – – 24.29 –
H9 30.77 – – – 8.57 –
H10 – – – – 18.57 –
H11 – – – – 15.71 –
Table 2. The minimum dissimilarity between major haplotypes in each of the six HLA genes (loci). 
Dissimilarity is defined as the percentage of SNP sites where two major haplotypes found at each locus exhibited 
different alleles (of the SNP sites). The minimum dissimilarity for each major haplotype is then defined as 
the least dissimilarity observed against all other major haplotypes, thus measuring the degree of dissimilarity 
between the two most similar major haplotypes. A number of haplotypes were selected at each locus as follows: 
the haplotype frequency ≥10% for HLA-A, -B, -C, and –DR; ≥6% for HLA-DQ and –DP in any of the study 
populations. The number of SNPs that were assayed commonly across the 12 study populations is shown in the 
parenthesis at each HLA locus. For example, at HLA-A locus, the H1 haplotype shows substantial differences 
in alleles at ≥11 of 39 commonly-assayed SNPs ( ≥28.21%) against the other haplotypes, i.e., H2-H9 at HLA-
A; H9, which is found in both Chinese and Indians but not in Japanese (see Fig. 5), is assumed to be relatively 
dissimilar to the other haplotypes, H1-H8, as its minimum dissimilarity is 30.77% (12 of 39SNPs).
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partially explained by diversity at the haplotype level; the distribution of major haplotypes in each of the HLA genes 
has been found to vary between the populations, particularly between Okinawa and mainland Japanese popula-
tions. The haplotype variations at the MHC appear to be manifested by the discernible differences in imputation 
accuracy, where population-specific panels can yield marginally better performance than even a combined East 
Asian panel, despite the substantial homogeneity observed between the Japanese populations.
While the first phase of our imputation analysis contrasted the accuracy with the HapMap JPT reference panel 
against the accuracy with the population-specific and East Asian combined panels, it should be highlighted that 
the conventional approach to SNP imputation is to use the largest possible cosmopolitan panel, which is generally 
formed by a combination of samples from all available reference populations. Our intent of current genetic com-
parison analysis was to highlight the point that, even within the homogenous mainland Japanese populations where 
the predominant genetic differences were seen for the inter-population frequencies of the major haplotypes but 
not for the haplotype classes, there were some gains by using well-matched samples from the same populations as 
reference. This is important from the perspective of HLA imputation, as it has previously been shown that the use 
of cosmopolitan panels does not always yield superior performance to a smaller but population-specific panel27,28.
While numerous studies have thus far reported the presence of complex linkage disequilibrium (LD) patterns 
at the MHC41–44, they have typically focused on global populations that are unambiguously genetically distinct. 
In contrast, our study has investigated the haplotype differences at HLA loci between seemingly homogeneous 
Japanese populations, by benchmarking the observations against two pairs of non-Japanese populations from East 
and South Asia. One natural extension is to investigate whether there exists any LD between HLA loci, since it 
has been previously shown that LD in the MHC region is uncharacteristically long due to the recent positive and 
balancing selection5,18. To pursue this, we calculated the extent of LD between the classical HLA alleles for a set of 
four Asian populations in the HapMap (CHB, JPT) and SGVP (CHS, INS) (Supplementary Table 3). We observed 
that there were indeed long stretches of LD between the neighbouring HLA gene loci in either Class I or Class II; 
consequently, alleles in two neighbouring HLA genes can be found on the same haplotype in a given population 
(such as HLA-B*52:01 and HLA-C*12:02 in JPT), although these correlations were rarely conserved across the four 
populations – even within an identical ethnic group, e.g., between CHB and CHS. In this line, a previous study45 
has reported that although there are some five-locus HLA haplotypes whose alleles exhibit strong LD, they are 
unique to Japanese and South Korean but not found in Chinese. Also, it has to be noted that the extent of genetic 
differences within the seven mainland Japanese populations is likely to be distinct between Class I and Class II 
gene loci even at the MHC (Supplementary Table 2). Another study46 has identified a recent positive selection 
on DPB1*04:01 in the Japanese individuals, which appears to have derived from the Korean population. Such 
locus-specific genetic differences in the HLA region warrant further investigation.
One may ask whether the population differentiation observed at the MHC extends to the rest of the genome, 
especially because in a study by Yamaguchi-Kabata and colleagues25, they could identify 20 regions outside the 
MHC that were highly differentiated between Ryukyu (Okinawa) and Hondo (mainland Japan) samples. We have 
examined the corresponding 20 non-MHC regions in our Japanese populations, and found similar results of genetic 
differentiation between the Okinawa and mainland Japanese populations in the majority of the regions with suf-
ficient coverage of genotype data (except in two regions, see Supplementary Table 4), thus providing concordant 
evidence for genetic differentiation between the individuals from Okinawa Prefecture and mainland Japanese.
Figure 6. Imputation performance across the study populations. The performance of imputing samples 
within each of the 12 study populations was measured by the discordance rate, defined as 1 – r2, where r2 
corresponds to the correlation between the observed genotype and the imputed allele dosage at 400 SNPs 
that were masked out of 1,607 SNPs in the MHC. For each of seven Japanese populations (except JPT), the 
imputation was performed on 19 additional samples which were not part of the main study and was used 
to construct the population-specific reference panel. On the other hand, the imputation at CHB, CHS, 
GIH and JPT were performed on 19 samples from the same population data, which was used to construct 
the reference panel and was thus subject to overfitting. The annotations of the reference panels used 
are as follow: JPTPanel = JPT; HAP_SGVPPanel = combined panel using the CHB, CHS, JPT samples; 
FukuokaPanel = Fukuoka; EhimePanel = Ehime; ShimanePanel = Shimane; AmaPanel = Amagasaki; 
Kita-NagoyaPanel = Kita-nagoya; TokyoPanel = Tokyo; OkinawaPanel = Okinawa; CHBPanel = CHB; 
CHSPanel = CHS.
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By virtue that the MHC is significantly more polymorphic than the rest of the genome, harbours one of the most 
biologically important regions in the genome and at the same time possesses long stretches of high LD, there is a 
need to acknowledge that broad metrics of imputation performance often calculated with input from across the 
genome may potentially mask important limitations with regard to imputation of SNPs in the HLA regions. Several 
studies47–49 have reported the risk of inaccuracies and confounding in genetic association studies in populations 
even with relatively small genetic differences. In this line, based on our data, we can further advocate caution in 
using a generic Japanese panel (e.g., JPT in the HapMap) for imputation of SNPs and HLA alleles in samples from 
Okinawa Prefecture.
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